Teva Octreotide for injectable suspension recalled due to potential drug quality issues
Critical priority
What you should do
- 1If you have an affected product, do not use it.
- 2Speak to your health care professional immediately to obtain an alternative or replacement product.
- 3If you are unsure whether your product is affected, check with your pharmacy.
- 4Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects.
- 5Return affected product(s) to the pharmacy where it was purchased for proper disposal.
The issue
Product quality
Affected product
All strengths of Teva Octreotide for Injectable Suspension Kit (DIN 02503751, 02503778 and 0253786) with the lot numbers noted below.
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.